Cordex Biologics Inc.
  • About us
  • Our Product
  • Science
  • Clinical Trials
  • News
  • Contact
  • English
    • Français
    • English
Select Page

Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore

by admin | Jul 16, 2026 | English

Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, is conditionally authorized by the European Commission for the treatment of certain hematological malignancies FarmaMondo has been granted distribution rights for Zemcelpro® in Argentina, Hong Kong and...

Recent Posts

  • Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
  • Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
  • Zemcelpro® (dorocubicel) positive results in high- and very high-risk blood cancers to be reported at the EBMT 2026 Annual Meeting
  • Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany
  • Zemcelpro® (UM171 Cell Therapy) improved outcomes compared with common graft sources: European real-world evidence

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • March 2026
  • February 2026
  • December 2025
  • August 2025
  • June 2025
  • June 2024
  • November 2023
  • August 2023

Categories

  • English